New prospects for PCSK9 inhibition?

Eur Heart J. 2018 Jul 14;39(27):2600-2601. doi: 10.1093/eurheartj/ehy147.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cardiovascular Diseases*
  • Humans
  • Hyperlipoproteinemia Type II*
  • Proprotein Convertase 9
  • Proprotein Convertases
  • Subtilisins

Substances

  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Proprotein Convertases
  • Subtilisins